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INTRODUCTION
Teratomas are embryonal tumours which originate
from primordial germ cell. They are derived from at
least two of  the three germ cell layers. Teratomas
involve the gonads as well as extragonadal parts of
the body. The sacroccocygeum represents the
commonest extragonadal location of  teratomas.
Sacroccocygeal teratoma (SCT) is the commonest
neoplasm of the fetus and newborn.
The incidence of SCT is 1 in 20,000 to 1 in 40,0001
Male to female ratio is 1:4.2 In most studies about
80% of SCT are benign (mature).The malignant
(immature) tumors are slightly more common in males
and in neonates (68%) and older children (73%).3
Patients with SCT may have some associated
abnormalities like anorectal malformations, spinal
defects and oesophageal fistula in about 10% -20%
of cases2. Early prenatal diagnosis is crucial in the
management and outcome of pregnancy and well-
being of both mother and child.
The presence of this tumour in a fetus can have
significant effect on the health of the pregnant mother
as it may be associated with severe anaemia, cardiac
failure, maternal mirror syndrome and even death. The
developing fetus with SCT is prone to high output
cardiac failure, hydrops, placentomegaly and
complications of  delivery.
Understanding a simple way of managing this condition
is important in developing countries to prevent
morbidities and mortalities. A simplified algorithm of
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Sacroccocygeal teratoma is the commonest tumour in neonates.
It is more common in females in about 80% of cases. Associated
congenital abnormalities may be seen coexisting with
sacroccocygeal teratomas in 10-20% of cases. Early diagnosis
can be made through fetal ultrasound scan (USS).The presence
of this tumour can have serious complications for both the
fetus and mother. Apart from USS other specialized tests can
be done, these may not be available in developing and low
resource countries. A simple algorithm of management using
USS and clinical findings can be adapted for use in these
locations.
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management will help in following the progress of
pregnancy in such women and also aid in determining
when and how to intervene. Some algorithms are
present in literature, none however is designed for the
developing countries where most centers are not
sufficiently equipped.
This article describes a simple algorithm that can be
adapted for developing countries in the management
of  fetal SCT.
PRENATAL DIAGNOSIS
Prenatal diagnosis is achieved by a maternal-fetal
ultrasound scan (USS).This show the tumour
protruding from the sacral region with or without
intrapelvic extension. Antenatal diagnosis is usually
made after 22 weeks of gestation.4 Some reported
cases of earlier prenatal diagnosis have been
documented.4 Routine USS can diagnose many cases
of  asymptomatic SCT. However the most common
indication for antenatal USS in fetal SCT has been a
uterus that is large for gestational age either due to
polyhydramnios or rapid growth of  the tumour.4
Screening methods such as amniotic fluid alpha-
fetoprotein or maternal serum screening have not
proven to be effective but can be used postnatally to
differentiate between benign and malignant SCT.5,6
Postnatal persistence in the level of  alpha-fetoprotein
may indicate a residual tumour, recurrence or malignant
transformation.7
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Other forms of  prenatal diagnostic modalities include
fetal magnetic resonance imaging (MRI), fetal
echocardiography and doppler echocardiography. Fetal
MRI is observed to give a clearer configuration of
the tumour than USS.
 In the developing countries these modalities are not
readily available in most hospitals. In the few hospital
where these investigations are available, they not
affordable. This makes USS the most readily available
investigative tool for evaluation and monitoring.
Prenatal problems and interventions
The fetus with SCT is at high risk of prenatal and
perinatal complications. The natural history and
pathophysiology of  fetal SCT is different from that
of  postnatally diagnosed SCT. Survival of  the fetuses
with SCT is dependent on anticipation and recognition
of the pathophysiologic events and optimal obstetric
and surgical management9.
Postulated causes of  perinatal deaths include hydrops,
dystocia, tumour rupture, preterm labour secondary
to polyhydramnios and anaemia due either to
haemorrhage or haemolysis within the tumour8.
Most SCT diagnosed before birth can be managed
by planned delivery and postnatal surgery. However,
large tumours early in pregnancy may result in
placentomegaly, hydrops, fetal death and a
preeclampsia-like syndrome in the mother. This chain
of events may result from high output cardiac failure
in the fetus caused by arteriovenous shunting through
the tumour.10
The possible prenatal interventions include
amnioncentesis, debulking, open fetal surgery and
delivery. In the developing countries many hospitals
do not have facilities and manpower for most of these
specialized interventions. The only feasible option in
most cases is to deliver the fetus. When and how to
deliver is explained by this simple algorithm.
DISCUSSION
A routine fetal USS can be used to make a diagnosis
of  fetal SCT. USS is readily available in many hospitals
in the developing countries. It can be used to also
monitor the size of  the tumor as pregnancy progresses.
In the absence of any complications the pregnancy is
closely monitored with regular scanning until when the
pregnancy is term. At term a decision is taken to deliver
the fetus. The choice of  mode of  delivery will be
dependent on the size of  the tumor. If  it is less than
5cm vaginal delivery can be allowed. If greater than
5cm or in the presence of polyhydramnios elective
caesarean section can be carried out.
However if during the course of pregnancy
complications arise either in the fetus or mother the
line of  decision changes. If  the fetus is preterm a choice
of  termination of  pregnancy can be taken. If  however
the complications arise at a time when the fetus is term
 Fig. 1: Simple algorithm in the management of  fetal SCT
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or can withstand extrauterine life an emergency
caesarean section is done.
This algorithm is cheap to use and can easily be adapted
to locations were specialized facilities are absent.
CONCLUSION
Management of sacroccocygeal teratoma can be
simplified and individualized to achieve good outcome
in communities where specialized facilities are absent.
Appropriate use of USS along with good clinical
judgement can help save the lives of many fetuses and
their mothers with this condition.
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